These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30316467)

  • 1. Multiparametric MR Imaging of Benign and Malignant Bone Lesions.
    Tang H; Ahlawat S; Fayad LM
    Magn Reson Imaging Clin N Am; 2018 Nov; 26(4):559-569. PubMed ID: 30316467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla?
    Del Grande F; Ahlawat S; Subhawong T; Fayad LM
    J Magn Reson Imaging; 2017 Feb; 45(2):390-400. PubMed ID: 27417663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
    Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
    Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
    Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
    Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
    Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI biomarkers in osseous tumors.
    Fukuda T; Wengler K; de Carvalho R; Boonsri P; Schweitzer ME
    J Magn Reson Imaging; 2019 Sep; 50(3):702-718. PubMed ID: 30701624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.
    Soldatos T; Ahlawat S; Montgomery E; Chalian M; Jacobs MA; Fayad LM
    Radiology; 2016 Mar; 278(3):831-40. PubMed ID: 26390048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.
    Del Grande F; Subhawong T; Weber K; Aro M; Mugera C; Fayad LM
    Radiology; 2014 May; 271(2):499-511. PubMed ID: 24495264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value added: functional MR imaging in management of bone and soft tissue sarcomas.
    Subhawong TK; Wilky BA
    Curr Opin Oncol; 2015 Jul; 27(4):323-31. PubMed ID: 26049272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.
    Tao X; Yang G; Wang P; Wu Y; Zhu W; Shi H; Gong X; Gao W; Yu Q
    Dentomaxillofac Radiol; 2017 Aug; 46(6):20160434. PubMed ID: 28299943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Features of Bone Tumors: Conventional Radiographs and MR Imaging Correlation.
    Gemescu IN; Thierfelder KM; Rehnitz C; Weber MA
    Magn Reson Imaging Clin N Am; 2019 Nov; 27(4):753-767. PubMed ID: 31575404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.